	The real diagnostic value of serum iron in iron deficiency anemia among patients with inflammatory bowel disease: A retrospective study. J Int Med Res Tang JT, Wang X, Chen H, He GB. PMID: 42087743 [PubMed - indexed for MEDLINE]
	Multi-omics-based machine learning model predicts response and guides treatment in Crohn disease: a case study in nutritional therapy. Inflamm Bowel Dis Azulay A, Gotesdyner L, Aharoni-Frutkoff Y, Focht G, Talmor Y, Borenstein E, Plotkin L, Orlanski-Meyer E, Lev-Tzion R, Ledder O, Yogev D, Assa A, Broide E, Yerushalmy-Feler A, Kierku, Schwerd T, Wine E, Turner D. PMID: 42086326 [PubMed - as supplied by publisher]
	Effectiveness and safety of mirikizumab in ulcerative colitis: real-world data from the Latium Net. BMJ Open Gastroenterol Murgiano M, Balestrieri P, Calabrese E, Fiorino G, Festa S, Pugliese D, Di Vincenzo F, Puca P, Parello S, Vespasiano V, Colella A, Marafini I, Profeta F, Foscarini E, Papa A, Lopetuso LR, Monteleone G, Cicala M, Gasbarrini A, Laterza L, Scaldaferri F. PMID: 42086294 [PubMed - indexed for MEDLINE]
	Transfer of faeces in ulcerative colitis 2: improving efficacy - study protocol for a multicentre randomised controlled trial (TURN2 study). BMJ Open Bénard MV, Van Der Spek MJ, Davids M, Visser CE, Zoetendal EG, Rethans B, Zwezerijnen-Jiwa FH, Visschedijk MC, Ponsioen CY, Oldenburg B, Weersma RK. PMID: 42086265 [PubMed - indexed for MEDLINE]
	Improvement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease Treated With Risankizumab Versus Ustekinumab in the Phase 3B SEQUENCE Study. Am J Gastroenterol Loftus EV Jr, Joshi N, Sands BE, Jairath V, Blumenstein I, Shukla N, Kligys K, Anschutz T, Griffith J, Zambrano J, Louis E. PMID: 42085631 [PubMed - as supplied by publisher]
	Multi-modal therapeutic approaches to inflammatory bowel disease: plant-derived compounds, nanoparticle drug delivery systems, and gene-based interventions. Mol Biol Rep Komal A, Ilyas D, Khan MU, Rehman MKU, Hassan T, Ayub H, Naqi N, Ullah N, Ilyas U. PMID: 42084709 [PubMed - indexed for MEDLINE]
	The evaluation of motor deficits in children with ulcerative colitis: a cross-sectional study. Eur J Pediatr Akbulut UE, Atalay A, Isik , Sivil N, Sar, Birsen G, Kara OK, Kara K, Ulu HS, . PMID: 42081144 [PubMed - indexed for MEDLINE]
	Physical, cognitive, and psychosocial fatigue are differently related to cortical complexity of superior temporal and frontal brain regions in Crohn's disease. Front Neuroimaging McIver TA, Bernstein CN, Marrie RA, Fisk JD, Figley CR, Kornelsen J. PMID: 42079741 [PubMed]
	Development and validation of a predictive nomogram for response to biologics and targeted therapy in Crohn's disease: a retrospective cohort study. Front Immunol Lin P, Wang W, Zhou Y, Yang Y, Liu P. PMID: 42079671 [PubMed - indexed for MEDLINE]
	SIRL-1 deficiency reveals pro-inflammatory IL-8 axis in inflammatory bowel disease: a novel diagnostic ratio. Front Immunol Wang Z, Li S, Tan Q, Sang J, Xu Z, Ding X, Yao X, Chen N, Yu S, Zong M, Lu Y, Zhong L, Fan L. PMID: 42079633 [PubMed - indexed for MEDLINE]
	Latent profiles of self-management behavior and associated factors among Chinese patients with ulcerative colitis. Front Public Health Yang M, An H, Lei L, Chen Y, Wang Y, Jiang X, Luo X. PMID: 42077983 [PubMed - indexed for MEDLINE]
	Diagnostic Challenges and Management of Crohn's Disease: The Value of Capsule Endoscopy. Cureus Alexander S, Hazzard I, Byer AA, Davies Y. PMID: 42077712 [PubMed]
	Leucine-Rich Alpha-2 Glycoprotein Is an Accurate Serum Marker for Endoscopic and Histological Remission in Ulcerative Colitis. Inflamm Intest Dis Kawamoto A, Fujii T, Tanaka S, Watanabe S, Tomii S, Takenaka K, Hibiya S, Morikawa R, Tamura A, Shimizu H, Kurosaki M, Yauchi T, Ohtsuka K, Okamoto R. PMID: 42077409 [PubMed]
	Hydrodynamic Delivery of IL-10 Gene for Local Immunomodulation in Human Crohn's Disease Tissue: A Proof-of-Concept Study. Pharmaceutics Sendra L, Giner F, Olivera-Pasquini GG, José Herrero M, Zucchet EG, Aliño SF, Frasson M. PMID: 42076094 [PubMed]
	Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial. Pharmaceuticals (Basel) Khrieba MO, Abdulelah FM, Badawoud AM, Hamza E, Al-Dhelaan RA, Ahmed TI, Abdelhameed AG, Elshorbagi N, El-Hanafy DA, Eltantawy N, Salahuddin MM, Elkhodary NM, Radwan KH, Khalaf Ali KAB, El-Sayed AA, Kamal M. PMID: 42075807 [PubMed]
	The Role of Microbiota and Fecal Transplantation in Inflammatory Bowel Disease. Pathogens Lagos I, Pérez de Arce E, Faggiani I, D'Amico F, Zilli A, Furfaro F, Massironi S, Cicerone C, Solitano V, Parigi TL, Peyrin-Biroulet L, Danese S, Allocca M. PMID: 42075777 [PubMed - indexed for MEDLINE]
	Dysregulated IL-7/IL-7R-CD132 Axis and Intestinal Microsporidiosis in Crohn's Disease. Pathogens Hurtado-Marcos C, Izquierdo F, Fenoy S, Águila CD, Pérez-Griera J, Benlloch S, Amorós C, Ballesteros CG, Chuliá FL, Andreu-Ballester JC, Cuéllar C. PMID: 42075756 [PubMed - indexed for MEDLINE]
	Seroprevalence of Borrelia burgdorferi Antibodies in Patients with Ulcerative Colitis and Its Association with Disease Activity. Pathogens Aydin G, Akyol T. PMID: 42075735 [PubMed - indexed for MEDLINE]
	The Overlap Between Crohn's Disease and Intestinal Tuberculosis: A Never-Ending Story. Medicina (Kaunas) Cazacu SM, Streba CT, Constantin C, Ionele CM, Rogoveanu I, Popescu AV, Florescu MM. PMID: 42075665 [PubMed - indexed for MEDLINE]
	Predictive Utility of the Vedolizumab Clinical Decision Support Tool in a Real-World IBD Cohort: Differential Performance in Crohn's Disease and Ulcerative Colitis. Medicina (Kaunas) Ocepek A, Molinari N, Ma, Zmazek J, Nikoli. PMID: 42075594 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 57501

Page 1 of 2876



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy